Athens Research and Technology

Athens Research and Technology

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Athens Research and Technology is a long-established, private biotechnology company that operates as a specialized supplier and service provider in the proteomics and antibody sectors. Its core business is the purification and manufacture of high-quality human and animal proteins, which are critical reagents for academic research, pharmaceutical proof-of-concept studies, and diagnostic kit manufacturing. The company emphasizes its ISO9001:2015 certified facility, custom purification services, and direct-to-customer sales model, positioning itself as a trusted partner for high-purity biological materials. It is preparing for a rebranding under a new name effective April 2026.

OncologyMetabolic DiseasesInflammationAutoimmune DiseaseCardiovascular DiseaseAlzheimer's Disease

Technology Platform

Expertise in purification of proteins from native human and animal sources (plasma, erythrocytes, neutrophils, tissues) using chromatography and other biochemical techniques. Specializes in low-endotoxin and immunogen-grade proteins.

Opportunities

Growth is driven by increasing demand for high-quality native proteins in biotherapeutic development, biomarker discovery, and the expanding in-vitro diagnostics market.
The company's custom services and bulk manufacturing capabilities position it to form deeper partnerships with pharmaceutical and diagnostic manufacturers.

Risk Factors

Key risks include reliance on the supply of human/animal source materials, competition from recombinant protein technologies, and potential regulatory changes affecting biological source materials.
Its niche focus could be disrupted by advances in synthetic biology.

Competitive Landscape

Competes with large, diversified life science reagent suppliers (e.g., Thermo Fisher, Merck) and specialized recombinant protein producers. Its differentiation lies in its expertise with native protein purification, offering post-translationally modified proteins that are critical for certain research and diagnostic applications.